Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. GH
GH logo

GH

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

GH News

UnitedHealth Expands Coverage for Shield Blood Test for Colorectal Cancer

6d agoNewsfilter

Guardant Shield Blood Test Gains Coverage from UnitedHealth

6d agostocktwits

UnitedHealth to Cover Guardant Shield Test, Boosting GH Stock

6d agoseekingalpha

Guardant Health Shares Surpass Analyst Target Price

Jun 29 2026NASDAQ.COM

Micron's Strong Earnings Boost Chip Stocks

Jun 25 2026Yahoo Finance

Futures Rise as South Korea's Kospi Index Jumps

Jun 24 2026Yahoo Finance

RBC Capital Markets Initiates Guardant Health with Outperform Rating

Jun 12 2026seekingalpha

Biotech Sector Sees Surge in FDA and Global Approvals

Jun 12 2026NASDAQ.COM

Latest Ratings and Outlook from Wall Street

Jun 12 2026CNBC

Guardant360 CDx Receives FDA Approval for Cancer Diagnosis

Jun 11 2026NASDAQ.COM

Guardant360 CDx Receives FDA Approval as Companion Diagnostic

Jun 11 2026NASDAQ.COM

FDA Approves Guardant360 CDx for HERNEXEOS Treatment

Jun 11 2026Newsfilter

Grail: A Potential Sleeper Stock in Liquid Biopsies

Jun 08 2026Fool

Grail's Multi-Cancer Early Detection Test Awaits FDA Approval

Jun 08 2026NASDAQ.COM

Latest Ratings and Outlook from Wall Street

Jun 05 2026CNBC

Latest Rating Changes on Wall Street

Jun 02 2026CNBC